Louis W. Sullivan, Director at Emergent BioSolutions Inc. (EBS), sold 29,640 shares at $35.34 ($1.0M) on 2016-03-10, disclosed to the SEC on 2016-03-14.
Open-market sale of $1.0M EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.34 | 14,820 | $524K | 50.0% |
| 2 | $35.34 | 14,820 | $524K | 50.0% |
| Total | $35.34 avg | 29,640 | $1.0M | 100% |
| Filing → |
| UTHR | SELL | 2024-05-06 | $2.7M | — | Filing → |
| UTHR | SELL | 2023-03-02 | $172K | — | Filing → |
| UTHR | SELL | 2023-02-02 | $183K | — | Filing → |